Korean Diabetes J.  2010 Aug;34(4):261-262. 10.4093/kdj.2010.34.4.261.

Letter: Effects of Rosiglitazone on Inflammation in Otsuka Long-Evans Tokushima Fatty Rats (Korean Diabetes J 2010;34:191-9)

• Yang SJ
• Park CY

• KMID: 2029880
• DOI: http://doi.org/10.4093/kdj.2010.34.4.261

Abstract

No abstract available.

MeSH Terms

Animals
Inflammation
Rats
Thiazolidinediones
Thiazolidinediones

Reference

1. Shoelson SE, Lee J, Goldfine AB. Inflammation and insulin resistance. J Clin Invest. 2006. 116:1793–1801.

2. Olefsky JM. Treatment of insulin resistance with peroxisome proliferator-activated receptor gamma agonists. J Clin Invest. 2000. 106:467–472.

3. Ferre P. The biology of peroxisome proliferator-activated receptors: relationship with lipid metabolism and insulin sensitivity. Diabetes. 2004. 53:Suppl 1. S43–S50.

4. Remels AH, Langen RC, Gosker HR, Russell AP, Spaapen F, Voncken JW, Schrauwen P, Schols AM. PPARgamma inhibits NF-kappaB-dependent transcriptional activation in skeletal muscle. Am J Physiol Endocrinol Metab. 2009. 297:E174–E183.

5. Mohanty P, Aljada A, Ghanim H, Hofmeyer D, Tripathy D, Syed T, Al-Haddad W, Dhindsa S, Dandona P. Evidence for a potent antiinflammatory effect of rosiglitazone. J Clin Endocrinol Metab. 2004. 89:2728–2735.

6. Jiang C, Ting AT, Seed B. PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines. Nature. 1998. 391:82–86.

7. Lee JW, Nam-Goong IS, Kim JG, Yun CH, Kim SJ, Choi JI, Kim YI, Kim ES. Effects of rosiglitazone on inflammation in Otsuka Long-Evans Tokushima Fatty rats. Korean Diabetes J. 2010. 34:191–199.

8. Krebs M, Roden M. Molecular mechanisms of lipid-induced insulin resistance in muscle, liver and vasculature. Diabetes Obes Metab. 2005. 7:621–632.

9. Delarue J, Magnan C. Free fatty acids and insulin resistance. Curr Opin Clin Nutr Metab Care. 2007. 10:142–148.